Brief ReportSocial Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device
Section snippets
Acknowledgments
Disclosure: K. Flint, None; E. L. Chaussee, None; K. Henderson, None; K. Breathett, None; P. Khazanie, None; J. S. Thompson, None; C. K. McIlvennan, None; S. J. LaRue, None; D. D. Matlock, None; L. A. Allen, None
Funding
Funded through Patient-Centered Outcomes Research Institute (PCORI) Awards (CDR-1310-06998 and SDM-2017C2-8640). The views, statements, opinions in this work are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee. This work was also supported in part by the National Heart, Lung and Blood Institute (1K23HL105896-01, Allen), the Heart Failure Society of
References (10)
- et al.
The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships
J Heart Lung Transplant
(2019) - et al.
Caregiver status and outcomes after durable left ventricular assist device implantation
Heart Lung
(2017) The VA Transplant Program: a rebuttal to criticism and a look to the future
Am J Transplant
(2019)- et al.
A caveat to the MISSION Act: perspective from a Veterans Administration transplant center
Am J Transplant
(2019) - et al.
Impact of shared care in remote areas for patients with left ventricular assist devices
JACC Heart Fail
(2020)
There are more references available in the full text version of this article.
Cited by (0)
© 2020 Elsevier Inc. All rights reserved.